Type 2 Diabetes Medicines Exporter India to USA | City Drug House
City Drug House is a trusted exporter of Hepaglide 0.25 mg from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Noveltreat 0.25 mg Injection is a prescription medication containing Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and manage weight. It is a once-weekly subcutaneous injection designed to improve glycemic control and aid in weight loss.
Mechanism of Action:
Insulin Stimulation: Mimics the natural GLP-1 hormone to stimulate insulin release when blood sugar levels are high.
Appetite Regulation: Acts on brain receptors to reduce hunger and increase feelings of fullness.
Gastric Emptying: Slows gastric emptying, which helps manage calorie intake and glucose levels.
Glucose Regulation: Reduces glucose production by the liver.
Dosage & Administration: Noveltreat 0.25 mg/0.5 mL is a once-weekly, , pre-filled injection pen, often used as the initial dose for initiating therapy. It is injected under the skin (subcutaneously) in the abdomen, thigh, or upper arm.
Key Precautions
Contraindications: Not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Hypoglycemia Risk: When combined with insulin or sulfonylureas, there is an increased risk of low blood sugar.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House is a trusted exporter of Hepaglide 0.25 mg from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Noveltreat 0.25 mg Injection is a prescription medication containing Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and manage weight. It is a once-weekly subcutaneous injection designed to improve glycemic control and aid in weight loss.
Mechanism of Action:
Insulin Stimulation: Mimics the natural GLP-1 hormone to stimulate insulin release when blood sugar levels are high.
Appetite Regulation: Acts on brain receptors to reduce hunger and increase feelings of fullness.
Gastric Emptying: Slows gastric emptying, which helps manage calorie intake and glucose levels.
Glucose Regulation: Reduces glucose production by the liver.
Dosage & Administration: Noveltreat 0.25 mg/0.5 mL is a once-weekly, , pre-filled injection pen, often used as the initial dose for initiating therapy. It is injected under the skin (subcutaneously) in the abdomen, thigh, or upper arm.
Key Precautions
Contraindications: Not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Hypoglycemia Risk: When combined with insulin or sulfonylureas, there is an increased risk of low blood sugar.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
